Skip to Content
3 Articles
Formulation Engineering ×
Blockbuster Drug Patent Recent Expirations (2024–2031) and B2B Generic Licensing Opportunities
by PharpleQ
In the global pharmaceutical industry, the expiration of a molecule’s active compound patent is only the first hurdle. The true gateway to high-margin generic entry is navigating Formulation and Compo...
Asset Light Pharma B2B Partnerships Business Partnership CDMO / CMO Dossier Licensing - In/Out Formulation Engineering Pharma Portfolio Expansion Pharma Sourcing Partnerships PharpleQ PharpleQ Lifesciences Pvt. Ltd.
0 21
Clinical Personal Care at Scale: Capitalizing on India's Surging Full-Spectrum Cosmeceutical Export Engine
by PharpleQ
The global beauty and personal care industry is experiencing an unprecedented structural shift. Driven by an increasingly well-informed consumer base, market demand has permanently evolved away from t...
Asset Light Pharma CDMO / CMO Contract Manufacturing Cosmeceutical Products Formulation Engineering India’s Healthcare Market Pharma Portfolio Expansion Pharma Sourcing Partnerships PharpleQ PharpleQ Lifesciences Pvt. Ltd. Regulatory Compliance Third-Party Manufacturing
0 49